K. Matsumura et al., DEFICIENCY OF DYSTROPHIN-ASSOCIATED PROTEINS IN DUCHENNE MUSCULAR-DYSTROPHY PATIENTS LACKING COOH-TERMINAL DOMAINS OF DYSTROPHIN, The Journal of clinical investigation, 92(2), 1993, pp. 866-871
Dystrophin, the protein product of the Duchenne muscular dystrophy (DM
D) gene, is a cytoskeletal protein tightly associated with a large oli
gomeric complex of sarcolemmal glycoproteins including dystroglycan, w
hich provides a linkage to the extracellular matrix component, laminin
. In DMD, the absence of dystrophin leads to a drastic reduction in al
l of the dystrophin-associated proteins, causing the disruption of the
linkage between the subsarcolemmal cytoskeleton and the extracellular
matrix which, in turn, may render muscle cells susceptible to necrosi
s. The COOH-terminal domains (cysteine-rich and carboxyl-terminal) of
dystrophin have been suggested to interact with the sarcolemmal glycop
rotein complex. However, truncated dystrophin lacking these domains wa
s reported to be localized to the sarcolemma in four DMD patients rece
ntly. Here we report that all of the dystrophin-associated proteins ar
e drastically reduced in the sarcolemma of three DMD patients in whom
dystrophin lacking the COOH-terminal domains was properly localized to
the sarcolemma. Our results indicate that the COOH-terminal domains o
f dystrophin are required for the proper interaction of dystrophin wit
h the dystrophin-associated proteins and also support our hypothesis t
hat the loss of the dystrophin-associated proteins in the sarcolemma l
eads to severe muscular dystrophy even when truncated dystrophin is pr
esent in the subsarcolemmal cytoskeleton.